Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting.

cell-free DNA citrullinated histone H3 outcome peripheral artery disease platelet reactivity

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
22 Jan 2020
Historique:
received: 16 12 2019
revised: 14 01 2020
accepted: 16 01 2020
entrez: 26 1 2020
pubmed: 26 1 2020
medline: 26 1 2020
Statut: epublish

Résumé

Neutrophil extracellular traps (NETs) are supposed to play a central role in atherothrombosis. We measured circulating citrullinated histone H3 (H3Cit) and cell-free DNA (cfDNA), which serve as surrogate markers of NET formation, in 79 patients with peripheral artery disease (PAD) following infrainguinal angioplasty with stent implantation. Analysis of cfDNA and H3Cit was performed using Quant-iT™ PicoGreen

Identifiants

pubmed: 31979010
pii: jcm9020304
doi: 10.3390/jcm9020304
pmc: PMC7073960
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Science. 2014 Dec 5;346(6214):1234-8
pubmed: 25477463
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Eur Heart J. 2016 May 14;37(19):1538-49
pubmed: 26761950
Thromb Haemost. 2019 Apr;119(4):542-552
pubmed: 30731493
J Thromb Haemost. 2018 Mar;16(3):508-518
pubmed: 29325226
Blood. 2015 Jul 9;126(2):242-6
pubmed: 25979951
PLoS One. 2015 Jun 09;10(6):e0129666
pubmed: 26058047
Nat Med. 2010 Aug;16(8):887-96
pubmed: 20676107
Atherosclerosis. 2014 Jan;232(1):119-24
pubmed: 24401225
Thromb Haemost. 2015 Apr;113(4):806-12
pubmed: 25428141
Thromb Haemost. 2009 Feb;101(2):333-9
pubmed: 19190818
Semin Thromb Hemost. 2016 Apr;42(3):191-204
pubmed: 26926581
J Endovasc Ther. 2016 Oct;23(5):738-43
pubmed: 27328913
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030
pubmed: 31303293
Immunol Res. 2017 Jun;65(3):706-712
pubmed: 28161762
Thromb Haemost. 2018 Jun;118(6):1078-1087
pubmed: 29672788
Front Immunol. 2016 Jul 06;7:271
pubmed: 27458459
Vasc Health Risk Manag. 2019 Jul 01;15:187-208
pubmed: 31308682
Int Angiol. 2018 Aug;37(4):327-334
pubmed: 29936722
Eur J Clin Invest. 2018 Feb;48(2):
pubmed: 29226390
Blood. 2017 Feb 23;129(8):1021-1029
pubmed: 27919911
Cardiovasc Res. 2019 Jul 1;115(8):1266-1285
pubmed: 30918936
PLoS One. 2012;7(12):e51862
pubmed: 23251644
Thromb Haemost. 2014 Oct;112(4):659-65
pubmed: 25265341
PLoS One. 2018 Jan 11;13(1):e0191231
pubmed: 29324871
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1977-84
pubmed: 25012129
PLoS One. 2018 Jan 2;13(1):e0190728
pubmed: 29293656
Circ Res. 2015 Mar 27;116(7):1182-92
pubmed: 25547404
Atherosclerosis. 2015 Aug;241(2):507-32
pubmed: 26117398
Eur Heart J. 2015 Jun 7;36(22):1405-14
pubmed: 25660055
Thromb Res. 2019 Mar;175:46-52
pubmed: 30703701
Thromb Haemost. 2017 Oct 5;117(10):1919-1929
pubmed: 28837206
Nat Rev Cardiol. 2018 Jun;15(6):332-350
pubmed: 29679023
J Pharmacol Exp Ther. 2013 Jun;345(3):430-7
pubmed: 23536315
Eur Heart J. 2015 Jun 7;36(22):1394-404
pubmed: 25755115
Thromb Haemost. 2014 Mar 3;111(3):474-82
pubmed: 24196591
J Vasc Surg. 2005 Apr;41(4):610-7
pubmed: 15874924
Br J Haematol. 2019 Jul;186(2):311-320
pubmed: 30968400
J Thromb Haemost. 2011 Sep;9(9):1795-803
pubmed: 21711444
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2032-2040
pubmed: 23818485
Thromb Haemost. 2013 Feb;109(2):290-7
pubmed: 23238559
J Immunol. 2012 Sep 15;189(6):2689-95
pubmed: 22956760
J Clin Med. 2019 Oct 01;8(10):
pubmed: 31581493
Blood. 2011 Aug 18;118(7):1952-61
pubmed: 21673343
Eur Heart J. 2015 Jun 7;36(22):1364-6
pubmed: 25845929
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Blood. 2014 Apr 17;123(16):2573-84
pubmed: 24335230

Auteurs

Svitlana Demyanets (S)

Department of Laboratory Medicine, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Stefan Stojkovic (S)

Department of Internal Medicine II, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Lisa-Marie Mauracher (LM)

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Christoph W Kopp (CW)

Department of Internal Medicine II, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Johann Wojta (J)

Department of Internal Medicine II, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.
Core Facilities, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Johannes Thaler (J)

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Simon Panzer (S)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.

Thomas Gremmel (T)

Department of Internal Medicine II, Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.
Department of Internal Medicine, Cardiology and Nephrology, Landesklinikum Wiener Neustadt, Corvinusring 3-5, 2700 Wiener Neustadt, Austria.

Classifications MeSH